Procedure May Make PSA Results More Reliable, Researchers Say

The prostate-specific antigen blood test, long considered the gold standard in screening for the disease, has been under heavy fire recently because of the number of false positives it produces. Although credited in some studies for lowering the metastatic prostate cancer rate by as much as 50 percent during the heyday of its use, this test has been taken off the table for routine screening of low-risk men.

Researchers in Ottawa, Canada, however, believe there is a procedure that might help make the PSA and its findings more reliable. Their study found that repeating the simple blood draw before taking action can dramatically enhance the reliability of findings.

?PSA false positives, unfortunately, led many men to undergo biopsies that were ultimately deemed unnecessary when cancer was not found,? explains Dr. Gregory Echt, founder and lead surgeon at the Prostate Seed Institute. ?Since biopsies themselves can lead to side effect risks, screening recommendations recently changed to remove this blood test from routines involving men who are low risk for prostate cancer.?

While PSA false positive issues are well known, the test is also responsible for successfully enabling early detection in a number of cases. The reduction in metastatic prostate cancer diagnosis supports the benefits of the test, many say. The Canadian study found that men who underwent the test at least twice before interventions were taken were much more likely to actually present with prostate cancer. Essentially, doubling down on the testing may enable doctors to make further recommendations based on more reliable data. Two suspicious tests in a row stand as a strong indicator of prostate cancer?s presence, the study found.

Whether the findings will result in new screening recommendations down the road remains unclear. What is clear is that men who are age 50 or older should speak with their healthcare providers about prostate cancer risks and screening. Men who are at higher risk for the disease may find the PSA is still used for early detection. Those at lower risk will likely be offered different screening protocols. Regardless, early detection can save lives, making this discussion important for all men as they age.

About The Prostate Seed Institute
The Prostate Seed Institute is one of the country?s leading pioneers in prostate cancer treatment including prostate seed implementation, a fast and painless procedure that effectively treats prostate cancer in its earliest stages. With a team of oncology experts and a state-of-the-art facility, the Prostate Seed Institute provides prostate cancer patients with the most comprehensive treatment available. To see the Procedure Comparison Chart and learn more about the Prostate Seed InstituteCLICK HERE.

Company :-Prostate Seed Institute

User :- Gregory Echt

Email :-barrydcedric@gmail.com

Phone :-214-379-2700

Mobile:- -